111 related articles for article (PubMed ID: 7936419)
1. Receptor-mediated activation of G proteins is reduced in postmortem brains from Alzheimer's disease patients.
Wang HY; Friedman E
Neurosci Lett; 1994 May; 173(1-2):37-9. PubMed ID: 7936419
[TBL] [Abstract][Full Text] [Related]
2. Acetylcholine muscarinic M2 receptor stimulated [35S]GTP gamma S binding shows regional selective changes in Alzheimer's disease postmortem brain.
Cowburn RF; Wiehager B; Ravid R; Winblad B
Neurodegeneration; 1996 Mar; 5(1):19-26. PubMed ID: 8731378
[TBL] [Abstract][Full Text] [Related]
3. Receptor-mediated activation of G proteins is increased in postmortem brains of bipolar affective disorder subjects.
Friedman E; Wang HY
J Neurochem; 1996 Sep; 67(3):1145-52. PubMed ID: 8752121
[TBL] [Abstract][Full Text] [Related]
4. Muscarinic acetylcholine receptor-stimulated binding of guanosine 5'-O-(3-thiotriphosphate) to guanine-nucleotide-binding proteins in cardiac membranes.
Hilf G; Gierschik P; Jakobs KH
Eur J Biochem; 1989 Dec; 186(3):725-31. PubMed ID: 2514098
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of guanosine 5'-O-(3-[35S] thiotriphosphate) binding by cholinergic muscarinic receptors in membranes of rat olfactory bulb.
Olianas MC; Onali P
J Neurochem; 1996 Dec; 67(6):2549-56. PubMed ID: 8931489
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of muscarinic receptor-G-protein interaction in Alzheimer disease.
Ferrari-DiLeo G; Mash DC; Flynn DD
Mol Chem Neuropathol; 1995 Jan; 24(1):69-91. PubMed ID: 7755848
[TBL] [Abstract][Full Text] [Related]
7. Impaired phosphoinositide hydrolysis in Alzheimer's disease brain.
Jope RS; Song L; Li X; Powers R
Neurobiol Aging; 1994; 15(2):221-6. PubMed ID: 7838295
[TBL] [Abstract][Full Text] [Related]
8. Determinants of alpha 2-adrenergic receptor activation of G proteins: evidence for a precoupled receptor/G protein state.
Tian WN; Duzic E; Lanier SM; Deth RC
Mol Pharmacol; 1994 Mar; 45(3):524-31. PubMed ID: 8145737
[TBL] [Abstract][Full Text] [Related]
9. Coupling of M-cholinoceptors and A1 adenosine receptors in human myocardium.
Böhm M; Gierschik P; Schwinger RH; Uhlmann R; Erdmann E
Am J Physiol; 1994 May; 266(5 Pt 2):H1951-8. PubMed ID: 8203594
[TBL] [Abstract][Full Text] [Related]
10. Effects of an agonist, allosteric modulator, and antagonist on guanosine-gamma-[35S]thiotriphosphate binding to liposomes with varying muscarinic receptor/Go protein stoichiometry.
Jakubík J; Haga T; Tucek S
Mol Pharmacol; 1998 Nov; 54(5):899-906. PubMed ID: 9804625
[TBL] [Abstract][Full Text] [Related]
11. Regionally selective alterations in G protein subunit levels in the Alzheimer's disease brain.
O'Neill C; Wiehager B; Fowler CJ; Ravid R; Winblad B; Cowburn RF
Brain Res; 1994 Feb; 636(2):193-201. PubMed ID: 8012802
[TBL] [Abstract][Full Text] [Related]
12. Guanosine 5'-(gamma-[35S]thio)triphosphate autoradiography allows selective detection of histamine H3 receptor-dependent G protein activation in rat brain tissue sections.
Laitinen JT; Jokinen M
J Neurochem; 1998 Aug; 71(2):808-16. PubMed ID: 9681473
[TBL] [Abstract][Full Text] [Related]
13. Dissociation of guanosine 5'-[gamma-thio]triphosphate from guanine-nucleotide-binding regulatory proteins in native cardiac membranes. Regulation by nucleotides and muscarinic acetylcholine receptors.
Hilf G; Kupprion C; Wieland T; Jakobs KH
Eur J Biochem; 1992 Mar; 204(2):725-31. PubMed ID: 1541285
[TBL] [Abstract][Full Text] [Related]
14. Autoradiographic mapping of dopamine-D2/D3 receptor stimulated [35S]GTPgammaS binding in the human brain.
Sóvágó J; Makkai B; Gulyás B; Hall H
Eur J Neurosci; 2005 Jul; 22(1):65-71. PubMed ID: 16029196
[TBL] [Abstract][Full Text] [Related]
15. Loss of stimulatory effect of guanosine triphosphate on [(35)S]GTPgammaS binding correlates with Alzheimer's disease neurofibrillary pathology in entorhinal cortex and CA1 hippocampal subfield.
García-Jiménez A; Cowburn RF; Ohm TG; Lasn H; Winblad B; Bogdanovic N; Fastbom J
J Neurosci Res; 2002 Feb; 67(3):388-98. PubMed ID: 11813244
[TBL] [Abstract][Full Text] [Related]
16. Cholinergic activation of phosphoinositide signaling is impaired in Alzheimer's disease brain.
Jope RS; Song L; Powers RE
Neurobiol Aging; 1997; 18(1):111-20. PubMed ID: 8983039
[TBL] [Abstract][Full Text] [Related]
17. [Gamma-35S]GTP autoradiography allows region-specific detection of muscarinic receptor-dependent G-protein activation in the chick optic tectum.
Kurkinen KM; Koistinaho J; Laitinen JT
Brain Res; 1997 Sep; 769(1):21-8. PubMed ID: 9374269
[TBL] [Abstract][Full Text] [Related]
18. Differential effects on [35S]GTPgammaS binding using muscarinic agonists and antagonists in the gerbil brain.
Pilar-Cuéllar F; Paniagua MA; Mostany R; Pérez CC; Fernández-López A
J Chem Neuroanat; 2005 Oct; 30(2-3):119-28. PubMed ID: 16095872
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of G-proteins in human control and Alzheimer's disease brain by FAD mutants of APP(714-723): implication of oxidative mechanisms.
Karelson E; Fernaeus S; Reis K; Bogdanovic N; Land T
J Neurosci Res; 2005 Feb; 79(3):368-74. PubMed ID: 15614786
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the G protein involved in the muscarinic stimulation of adenylyl cyclase of rat olfactory bulb.
Olianas MC; Onali P
Mol Pharmacol; 1996 Jan; 49(1):22-9. PubMed ID: 8569708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
